drugset
drugset / Trial / NCT00100607

Safety and Efficacy of AAE581 in Postmenopausal Women With Osteoporosis

NCT00100607 ↗

Phase 2 Completed 676 enrolled Novartis Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will test the safety and efficacy of AAE581 in increasing Lumbar Spine bone mineral density (BMD) at 12 months, by Dexa-scan (DXA) in postmenopausal women with osteoporosis.

Timeline

Start
2004-02
Primary completion
2005-09
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject balicatib Small molecule — —

Indications

osteoporosis